Wondering whether DexCom's current share price lines up with its underlying worth, or if the market is missing something ...

DexCom, Inc. today reported preliminary, unaudited results for the fourth quarter ended December 31, 2025 with total revenue of approximately $1.260 billion, an increase of 13% over the fourth quarter ...

DexCom, Inc. , the global leader in glucose biosensing, is ushering in the next era of transformative, customer-driven innovation under the leadership of President and CEO Jake Leach, who assumed his ...

Some of medtech's most innovative technologies were on display at the Consumer Electronics Show (CES) in Las Vegas this week.

There are exciting advancements in patient standard of care thanks to continuous health monitoring technologies.

FDA plans limited regulation of wearable medical devices, boosting Apple, Fitbit, Oura stocks as 50% of Americans use fitness ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

ViCentra has raised $13m in the second close of its Series D funding round that will be directed towards advancing ...

These technologies are improving all the time. If they’re not making claims that they are medical grade, let’s let the market ...

Wearable health devices may soon operate under looser regulatory oversight following new guidance from the FDA ...

Diabeloop receives US FDA 510(k) clearance for DBLG2, an automated insulin delivery algorithm: Grenoble, France Saturday, January 10, 2026, 10:00 Hrs [IST] Diabeloop, a global com ...

The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal ...